Mandate

Beijer Byggmaterial to acquire Bygg-Ole

October 10, 2018 M&A

Vinge has advised Beijer Byggmaterial AB (“Beijer Byggmaterial”) in connection with Beijer Byggmaterial entering into an agreement to acquire Nacka Trä & Byggvaror, Sven Gustafsson AB ("Bygg Ole"). Completion of the transaction is subject to customary conditions.

Bygg Ole is a family owned company with stores in Nacka, Värmdö, Märsta och Saltsjö Boo. Bygg Ole has an annual turnover of more than MSEK 700 and employs more than 200 employees. Beijer Byggmaterial is Sweden’s largest wholly owned retailer and distributor of building materials with 69 stores across Sweden. With the acquisition of Bygg Ole, Beijer Byggmaterial grows to have a total of 73 stores in Sweden. Beijer Byggmaterial is part of Stark Group, the largest retailer and distributor of building materials in the Nordic region with operations in Denmark, Greenland, Norway, Sweden and Finland. 

Vinge’s team consisted of, among others, Jonas Bergström, Linda Sengul and Anna Thoms (M&A), Hayaat Ibrahim (Corporate Commercial), Kristoffer Larsson (Real Property/Lease Agreements) and Xandra Ståhlberg (Anti Trust).
 

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025